id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-328090-bprnq9wx	Abdollahimajd, Fahimeh	Novel coronavirus 2019 (COVID‐19) and epidermolysis bullosa: report of three cases	2020-08-14		.txt	text/plain	571	22	29	High expression of ACE2 on keratinocytes reveals skin as a potential target for SARS-CoV-2 Molecular pathology of the basement membrane zone in heritable blistering diseases: The paradigm of epidermolysis bullosa Phenotypic spectrum of epidermolysis bullosa: The paradigm of syndromic versus non-syndromic skin fragility disorders Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic -Consensus: Recommendations by an international panel of experts Epidermolysis bullosa and the COVID-19 pandemic: challenges and recommendations Dystrophic epidermolysis bullosa: COL7A1 mutation landscape in a multi-ethnic cohort of 152 extended families with high degree of customary consanguineous marriages Recessive mutation in tetraspanin CD151 causes Kindler syndrome-like epidermolysis bullosa with multi-systemic manifestations including nephropathy Multigene next generation sequencing panel identifies pathogenic variants in patients with unknown subtype of epidermolysis bullosa: Subclassification with prognostic implications Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis The microbiome and atopic eczema: More than skin deep This article is protected by copyright. While an International consensus panel recently provided recommendations for prevention and multidisciplinary care of EB patients during the COVID-19 pandemic 4 , the phenotypic outcome in these patients in comparison to the general population has not been reported; however EB patients, particularly those with syndromic forms, may be at higher risk for infection with severe complications 4, 5 .	cache/cord-328090-bprnq9wx.txt	txt/cord-328090-bprnq9wx.txt
